Status:
COMPLETED
Pain Management Support Study for Cancer Survivors
Lead Sponsor:
Drexel University
Conditions:
Pain, Chronic
Opioid Use
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pain in cancer survivors is difficult to treat, and unrelieved pain can greatly reduce a person's quality of life. Opioids are often prescribed for pain management, yet they can have undesirable side ...
Detailed Description
As many as 40% of cancer survivors report experiencing chronic pain, and recent research indicates that pain is not well managed. Opioids are often prescribed during active cancer treatment for pain m...
Eligibility Criteria
Inclusion
- adult cancer survivors
- chronic pain for ≥ 3 months
- chronic opioid use (i.e., use of opioids for more than 90 days)
- willingness to reduce the amount of opioids currently taking
Exclusion
- history of polysubstance abuse/substance use disorder
- currently receiving methadone maintenance or suboxone treatment
- active psychosis or dementia
- inability to speak or write English
- moderate to severe hearing impairment
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT03782506
Start Date
November 1 2018
End Date
December 31 2021
Last Update
February 21 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hahnemann University Hospital
Philadelphia, Pennsylvania, United States, 19102
2
Thomas Jefferson Sidney Kimmel Cancer Center
Philadelphia, Pennsylvania, United States, 19107
3
Cancer Treatment Centers of America (CTCA)
Philadelphia, Pennsylvania, United States, 19124